BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34862099)

  • 21. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
    Mazzone E; Nazzani S; Preisser F; Tian Z; Marchioni M; Bandini M; Capitanio U; Kapoor A; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; I Karakiewicz P
    Cancer Epidemiol; 2018 Oct; 56():118-125. PubMed ID: 30173050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.
    Parker WP; Cheville JC; Frank I; Zaid HB; Lohse CM; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2017 Apr; 71(4):665-673. PubMed ID: 27287995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
    Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
    Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer.
    Larcher A; Trudeau V; Dell'Oglio P; Tian Z; Boehm K; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
    Urology; 2017 Apr; 102():130-137. PubMed ID: 27884597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
    An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
    Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
    Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
    Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
    Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
    Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.
    Bhindi B; Mason RJ; Haddad MM; Boorjian SA; Leibovich BC; Atwell TD; Weisbrod AJ; Schmit GD; Thompson RH
    Eur Urol; 2018 Feb; 73(2):254-259. PubMed ID: 28967553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morbidity of elective surgery for localized renal masses among elderly patients: A contemporary multicenter study.
    Borregales LD; Pecoraro A; Roussel E; Mari A; Grosso AA; Checcucci E; Montorsi F; Larcher A; Van Poppel H; Porpiglia F; Capitanio U; Minervini A; Albersen M; Serni S; Amparore D; Campi R
    Eur J Surg Oncol; 2023 Oct; 49(10):107014. PubMed ID: 37573666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
    Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
    Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status.
    Tomaszewski JJ; Uzzo RG; Kutikov A; Hrebinko K; Mehrazin R; Corcoran A; Ginzburg S; Viterbo R; Chen DY; Greenberg RE; Smaldone MC
    Urology; 2014 Apr; 83(4):843-9. PubMed ID: 24680455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robotic unclamped "minimal-margin" partial nephrectomy: ongoing refinement of the anatomic zero-ischemia concept.
    Satkunasivam R; Tsai S; Syan S; Bernhard JC; de Castro Abreu AL; Chopra S; Berger AK; Lee D; Hung AJ; Cai J; Desai MM; Gill IS
    Eur Urol; 2015 Oct; 68(4):705-12. PubMed ID: 26071789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
    Hjelle KM; Johannesen TB; Bostad L; Reisæter LAR; Beisland C
    Eur Urol Oncol; 2018 Aug; 1(3):252-261. PubMed ID: 31102628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
    Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
    BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
    Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
    Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.